1. Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients with Non-Small Cell Lung Cancer

Volume 20, Issue 12, December 2019, Pages 3591-3596

Hanifeh Mirtavoos-Mahyari; Mohsen Ghadami; Adnan Khosravi; Zahra Esfahani-Monfared; Sharareh Seifi; Elaheh Motevaseli; Mihan Pourabdollah; Mohammadhossein Modarressi

• View Article
• PDF 350.92 K

2. EGFR inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

Volume 20, Issue 1, January 2019, Pages 311-319

Zhifeng Yao; Peng Peng; Danghui Xu; Xuejun Zhou; Zhiyao Pan; Zhanfeng Li; Jianxin Yao; Jinfei Chen

• View Article
• PDF 388.54 K

3. Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinomas: A Single Center Study from Iran

Volume 19, Issue 1, January 2018, Pages 111-114

Ali Basi; Flora Khaledi; Mohammad Hadi Karbalaie Niya; Hamid Rezvani; Nasser Rakhshani

• View Article
• PDF 240.01 K

4. Roles of Immunohistochemical Staining in Diagnosing Pulmonary Squamous Cell Carcinoma

Volume 16, Issue 2, February 2015, Pages 551-557

• View Article
• PDF 3.27 MB

5. Frequency of EGFR Mutations in Non-small Cell Lung Cancer Patients: Screening Data from West Siberia

Volume 16, Issue 2, February 2015, Pages 689-692

• View Article
• PDF 381.58 K

6. Crosstalk between EGFR and p53 in Hepatocellular Carcinoma

Volume 15, Issue 19, December 2014, Pages 8069-8073

• View Article
• PDF 713.7 K

7. Concomitant EGFR Inhibitors Combined with Radiation for Treatment of Non-small Cell Lung Carcinoma

Volume 14, Issue 8, August 2013, Pages 4485-4494

• View Article
• PDF 425.27 K

8. Differences in Epidermal Growth Factor Receptor Gene Mutations and Relationship with Clinicopathological Features in NSCLC Between Uygur and Han Ethnic Groups

Volume 14, Issue 5, May 2013, Pages 2879-2883

• View Article
• PDF 420.83 K

9. Correlation Between EGFR Mutations and Serum TumorMarkers in Lung Adenocarcinoma Patients

Volume 14, Issue 2, February 2013, Pages 695-700

• View Article
• PDF 520.12 K

10. Association of Human Epidermal Growth Factor Receptor-2 Expression and Clinicopathological Findings in Patients with Colorectal Cancer

Volume 13, Issue 12, December 2012, Pages 6221-6225

• View Article
• PDF 651.53 K

11. Epidermal Growth Factor Receptor-Related DNA Repair and Radiation-Resistance Regulatory Mechanisms: A Mini-Review

Volume 13, Issue 10, October 2012, Pages 4879-4881

• View Article
• PDF 301.42 K

12. Histone Deacetylase Inhibitor Trichostatin A Enhances Antitumor Effects of Docetaxel or Erlotinib in A549 Cell Line

Volume 13, Issue 7, July 2012, Pages 3471-3476

• View Article
• PDF 1.16 MB

13. Efficacy and Safety of Vandetanib, a Dual VEGFR and EGFR Inhibitor, in Advanced Non-Small-Cell Lung Cancer: a Systematic Review and Meta-Analysis

Volume 12, Issue 11, November 2011, Pages 2857-2863

• View Article
• PDF 989.57 K